75 190

Cited 33 times in

The Effects of Ketorolac Injected via Patient Controlled Analgesia Postoperatively on Spinal Fusion

Authors
 Si-Young Park  ;  Seong-Hwan Moon  ;  Moon-Soo Park  ;  Kyung-Soo Oh  ;  Hwan-Mo Lee 
Citation
 YONSEI MEDICAL JOURNAL, Vol.46(2) : 245-251, 2005 
Journal Title
 YONSEI MEDICAL JOURNAL 
ISSN
 0513-5796 
Issue Date
2005
MeSH
Adult ; Aged ; Analgesia, Patient-Controlled* ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage* ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects* ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Case-Control Studies ; Drug Therapy, Combination ; Female ; Fentanyl/administration & dosage ; Fentanyl/therapeutic use ; Humans ; Injections, Intravenous ; Ketorolac/administration & dosage* ; Ketorolac/adverse effects* ; Ketorolac/therapeutic use ; Male ; Middle Aged ; Postoperative Care/adverse effects* ; Retrospective Studies ; Spinal Fusion*/standards ; Treatment Outcome
Keywords
Lumbar spine ; spinal fusion ; ketorolac
Abstract
Lumbar spinal fusions have been performed for spinal stability, pain relief and improved function in spinal stenosis, scoliosis, spinal fractures, infectious conditions and other lumbar spinal problems. The success of lumbar spinal fusion depends on multifactors, such as types of bone graft materials, levels and numbers of fusion, spinal instrumentation, electrical stimulation, smoking and some drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs). From January 2000 to December 2001, 88 consecutive patients, who were diagnosed with spinal stenosis or spondylolisthesis, were retrospectively enrolled in this study. One surgeon performed all 88 posterolateral spinal fusions with instrumentation and autoiliac bone graft. The patients were divided into two groups. The first group (n=30) was infused with ketorolac and fentanyl intravenously via patient controlled analgesia (PCA) postoperatively and the second group (n=58) was infused only with fentanyl. The spinal fusion rates and clinical outcomes of the two groups were compared. The incidence of incomplete union or nonunion was much higher in the ketorolac group, and the relative risk was approximately 6 times higher than control group (odds ratio: 5.64). The clinical outcomes, which were checked at least 1 year after surgery, showed strong correlations with the spinal fusion status. The control group (93.1%) showed significantly better clinical results than the ketorolac group (77.6%). Smoking had no effect on the spinal fusion outcome in this study. Even though the use of ketorolac after spinal fusion can reduce the need for morphine, thereby decreasing morphine related complications, ketorolac used via PCA at the immediate postoperative state inhibits spinal fusion resulting in a poorer clinical outcome. Therefore, NSAIDs such as ketorolac, should be avoided after posterolateral spinal fusion.
Files in This Item:
T200500116.pdf Download
DOI
10.3349/ymj.2005.46.2.245
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Orthopedic Surgery (정형외과학교실) > 1. Journal Papers
Yonsei Authors
Moon, Seong Hwan(문성환)
Park, Si Young(박시영)
Lee, Hwan Mo(이환모) ORCID logo https://orcid.org/0000-0002-5405-3832
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/147374
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links